Diabetes management in the primary care setting: summary (Q34997002)

5 August 2017

1 reference

title

Diabetes management in the primary care setting: summary (English)

1 reference

5 August 2017

Kevin A Peterson

1

1 reference

PubMed ID

12431760

5 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

American Journal of Medicine

5 August 2017

1 reference

5 August 2017

113 Suppl 6A

1 reference

5 August 2017

36S-40S

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901279-2

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901279-2

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901279-2

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901279-2

Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901279-2

Racial and ethnic differences in glycemic control of adults with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901279-2

Meeting American Diabetes Association guidelines in endocrinologist practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901279-2

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901279-2

NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901279-2

Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901279-2

Attitudes of primary care providers toward diabetes: barriers to guideline implementation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901279-2

Diabetes in urban African-Americans. IX. Provider adherence to management protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901279-2

Diabetes in urban African-Americans. XV. Identification of barriers to provider adherence to management protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901279-2

Diabetes in urban African-Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901279-2

Inhaled human insulin treatment in patients with type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901279-2

Application of a diabetes managed care program. The feasibility of using nurses and a computer system to provide effective care.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901279-2

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901279-2

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901279-2

10.1016/S0002-9343(02)01279-2

7 January 2021

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12431760